The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 15, 2022
Filed:
Jan. 28, 2021
The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);
Vanderbilt University, Nashville, TN (US);
The Uab Research Foundation, Birmingham, AL (US);
The Trustees of the University of Pennsylvania, Philadelphia, PA (US);
David J. Maloney, Point of Rocks, MD (US);
Alex Gregory Waterson, Nashville, TN (US);
Ganesh Rai Bantukallu, Arlington, VA (US);
Kyle Ryan Brimacombe, Bethesda, MD (US);
Plamen Christov, Nashville, TN (US);
Chi V. Dang, Penn Valley, PA (US);
Victor Darley-Usmar, Birmingham, AL (US);
Xin Hu, Frederick, MD (US);
Ajit Jadhav, Chantilly, VA (US);
Somnath Jana, Nashville, TN (US);
Kwangho Kim, Nashville, TN (US);
Jennifer L. Kouznetsova, Silver Spring, MD (US);
William J. Moore, Hagerstown, MD (US);
Bryan T. Mott, College Park, MD (US);
Leonard M. Neckers, Bethesda, MD (US);
Anton Simeonov, Bethesda, MD (US);
Gary Allen Sulikowski, Nashville, TN (US);
Daniel Jason Urban, Rockville, MD (US);
Shyh Ming Yang, Doylestown, PA (US);
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, Philadelphia, PA (US);
THE UAB RESEARCH FOUNDATION, Birmingham, AL (US);
VANDERBILT UNIVERSITY, Nashville, TN (US);
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, Bethesda, MD (US);
Abstract
Provided is a compound of formula (I), in which Ar, R, U, V, W, X, and p are as described herein. Also provided are methods of using a compound of formula (I), including a method of treating cancer, a method of treating a patient with cancer cells resistant to an anti-cancer agent, and a method of inhibiting lactate dehydrogenase A (LDHA) and/or lactate dehydrogenase B (LDHB) activity in a cell.